- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Attention Deficit and Disruptive Behavior Disorders in Japan
Total 506 results
-
Chiba UniversityCompletedAttention Deficit and Disruptive Behavior Disorders | Hyperkinesis | Attention Deficit Disorder With Hyperactivity DiseaseJapan
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Chiba UniversityCompletedAttention Deficit Disorder With HyperactivityJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Janssen Pharmaceutical K.K.CompletedAttention-Deficit / Hyperactivity DisorderJapan
-
Janssen Pharmaceutical K.K.CompletedAttention-Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of, Taiwan, Japan
-
Kurihama Medical and Addiction CenterUnknownPathological GamblingJapan
-
ShionogiEli Lilly and CompanyTerminated
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
ShionogiEli Lilly and CompanyCompletedDepressive DisorderJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompleted
-
Kyoto UniversityNagoya City UniversityCompleted
-
Showa UniversityCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompleted
-
Gunma UniversityCompletedSubthreshold DepressionJapan
-
Kibi International UniversityCompleted
-
Kibi International UniversityCompletedSubthreshold DepressionJapan
-
Nagoya City UniversityCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Chiba UniversityCompletedAdolescent | DepressionJapan
-
Aomori University of Health and WelfareCompleted
-
Japan Foundation for Neuroscience and Mental HealthNational Center of Neurology and Psychiatry, JapanCompleted
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)Japan
-
GlaxoSmithKlineCompleted
-
Otsuka Pharmaceutical Co., Ltd.H. Lundbeck A/SCompleted
-
Mochida Pharmaceutical Company, Ltd.PfizerCompleted
-
GlaxoSmithKlineCompletedDepressive DisorderJapan
-
Astellas Pharma IncCompleted
-
Eli Lilly and CompanyCompleted
-
Bristol-Myers SquibbCompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruiting
-
National Center of Neurology and Psychiatry, JapanCompletedAnxiety Disorders | Depressive DisordersJapan
-
Osaka City UniversityCompletedSSRI-Refractory Obsessive-Compulsive DisorderJapan
-
Kibi International UniversityUnknown
-
National Center of Neurology and Psychiatry, JapanTerminatedDepression | Alzheimer DiseaseJapan
-
Hamamatsu UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Komazawa UniversityCompletedCompassion | Social Anxiety DisorderJapan
-
Tadashi HasegawaCompleted